“Refined” COVID-19 Vaccine Program of Sanofi and GSK Launches Phase II Trial
#Sanofi and #GlaxoSmithKline have begun a new mid-stage study of a “refined” formulation of their adjuvanted recombinant protein-based...
Welcome to Mostly Microbes and Infectious Diseases. David Ojcius posts newspaper and journal articles in the broad field of microbiology.